MGZ 0.00% 2.0¢ medigard limited

Global Blood Collection Systems Market 2012-2016, page-10

  1. 12,188 Posts.
    lightbulb Created with Sketch. 437
    Slightly different product lines and different target markets. Also, I think, Unilife's product line is MAINLY for injecting substance whereas Medigard is MAINLY extraction (blood). Could be wrong as they could both have overlapping products (i.e. Unilife overlapping into Medigard market more so than the other way around).

    Unilife seems to targeted premium markets (Pharmaceuticals) whereas Medigard is chasing volume markets (Pathology).
 
watchlist Created with Sketch. Add MGZ (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.